Drug uptake in Sprague-Dawley rat striatum assessed per cm'3 at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 15 mins
Drug uptake in Sprague-Dawley rat striatum assessed per cm'3 at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 30 mins
Drug uptake in Sprague-Dawley rat striatum assessed per cm'3 at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 60 mins
Ratio of drug uptake in striatum to cerebellum of Sprague-Dawley rat at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 15 mins
Ratio of drug uptake in striatum to cerebellum of Sprague-Dawley rat at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 30 mins
Ratio of drug uptake in striatum to cerebellum of Sprague-Dawley rat at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 60 mins
Drug uptake in Sprague-Dawley rat striatum assessed as reduction of striatal binding potential at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 15 mins
Drug uptake in Sprague-Dawley rat striatum assessed as reduction of striatal binding potential at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 30 mins
Drug uptake in Sprague-Dawley rat striatum assessed as reduction of striatal binding potential at 37 MBq, iv treated 45 mins after DAT inhibitor GBR-12909 challenge measured after 60 mins